New findings from the Apple Heart Study indicate that Apple Watches can identify irregular heartbeats other than atrial fibrillation arrhythmias.
Funded by Apple and conducted by researchers from the Stanford University School of Medicine, the study has been ongoing since 2017. It has enrolled 419,297 Apple Watch and iPhone owners across the U.S. to study the company’s irregular heart rate-...
Editor's note: This story has been updated with information from Verily's announcement of the clearance.
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring.
The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
Among Apple’s many device and technology reveals today was an announcement that new health managing software would be built into Apple Watches. Starting Sept. 19, fitness-focused heart rate monitoring will be brought to the face of the watch, alongside warning notifications if an elevated heart rate is detected during a period of inactivity.
The consumer electronics giant will be using this...
A new study from the University of Buffalo showed that not only did AliveCor's smartphone-connected heart monitor detect as many arrythmias as a traditional 14-day cardiac event monitor, but patients were also considerably more adherent to the smartphone-connected device.
"The point of the study was to determine whether any smartphone app could be good enough to replace what we normally use now,...
Big news for the first startup shepherded by the West Wireless Health Institute: The FDA has greenlit Corventis' Nuvant system, a mobile cardiac telemetry system. The 510(k) clearance for Nuvant enables Corventis to begin marketing the service in the U.S. -- Corventis secured FDA clearance for its PiiX sensor (pictured), which is a part of the Nuvant system -- last April. According to the company...
CardioNet has announced new features for its cardiac remote monitoring and diagnostic MCOT system that give physicians more in-depth data. The new features will help physicians better diagnose atrial fibrillation, heart pauses, and ventricular tachycardia.
The company stated that the new features can be used in conjunction with CardioNet's SomNet program to help identify indications of sleep...
Inc. Magazine recognized at least one wireless health-focused company as among the fastest growing companies in the U.S. by revenue. eCardio Diagnostics was ranked the 117th fastest growing company in the U.S. with $21.4 million in revenue for 2008 and three year sales growth of 1,424 percent. eCardio was the 11th fastest growing health-focused company in the country, according to the magazine....
